Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer

por Tsang, R Y, Finn, R S
Publicado 2012

Late effects of treatment for early-stage Hodgkin's disease.

por Brierley, J. D., Rathmell, A. J., Gospodarowicz, M. K., Sutcliffe, S. B., Munro, A., Tsang, R., Pintilie, M.
Publicado 1998

How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

por Sawka, A M, Straus, S, Gafni, A, Brierley, J D, Tsang, R W, Rotstein, L, Ezzat, S, Thabane, L, Rodin, G, Meiyappan, S, David, D, Goldstein, D P
Publicado 2011

Thyroid cancer patients’ involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study

por Sawka, A. M., Straus, S., Gafni, A., Meiyappan, S., David, D., Rodin, G., Brierley, J. D., Tsang, R. W., Thabane, L., Rotstein, L., Ezzat, S., Goldstein, D. P.
Publicado 2011

Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration

por Bradley, D.T., Murphy, S., McWilliams, P., Arnold, S., Lavery, S., Murphy, J., de Lusignan, S., Hobbs, R., Tsang, R.S.M., Akbari, A., Torabi, F., Beggs, J., Chuter, A., Shi, T., Vasileiou, E., Robertson, C., Sheikh, A., Reid, H., O'Reilly, D.
Publicado 2022

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

por Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., McCowan, C., Agrawal, U., Shah, S. A., Ritchie, L. D., Murray, J., Pan, J., Bradley, D. T., Stock, S. J., Wood, R., Chuter, A., Beggs, J., Stagg, H. R., Joy, M., Tsang, R. S. M., de Lusignan, S., Hobbs, R., Lyons, R. A., Torabi, F., Bedston, S., O’Leary, M., Akbari, A., McMenamin, J., Robertson, C., Sheikh, A.
Publicado 2021